Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 30,221 | 20,882 | 26,839 | 26,158 | 34,529 |
| Operating Income | -29,221 | -20,882 | -26,839 | -26,158 | -34,529 |
| Other Income | 2,087 | 2,406 | 2,052 | 1,311 | 1,661 |
| Pre-tax Income | -27,134 | -18,476 | -24,787 | -24,847 | -32,868 |
| Income Tax | N/A | N/A | N/A | -1,133 | 17 |
| Net Income Continuous | -27,134 | -18,476 | -24,787 | -23,714 | -32,885 |
| Net Income | $-27,134 | $-18,476 | $-24,787 | $-23,714 | $-32,885 |
| EPS Basic Total Ops | -1.30 | -0.89 | -1.50 | -2.31 | -3.26 |
| EPS Basic Continuous Ops | -1.30 | -0.89 | -1.50 | -2.34 | -3.26 |
| EPS Diluted Total Ops | -1.30 | -0.89 | -1.50 | -2.31 | -3.26 |
| EPS Diluted Continuous Ops | -1.30 | -0.89 | -1.50 | -2.34 | -3.26 |
| EPS Diluted Before Non-Recurring Items | -1.30 | -0.89 | -1.50 | -2.30 | -3.30 |
| EBITDA(a) | $-28,849 | $-20,368 | $-26,175 | $-25,249 | $-33,180 |